CRScube acquires Mednet to expand global eClinical capabilities
SEOUL, South Korea and MINNEAPOLIS, Nov. 18, 2025 /PRNewswire/ -- CRScube has announced the successful acquisition of Mednet, marking a key...
Clinical Trial
BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine
Proprietary agentic AI model transforms genomic and real-world data into actionable insights across the full drug lifecycle Enables faster development of...
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on...
D.C. Circuit Grills DEA Over Years Long Delays as MMJ BioPharma Cultivation Demands Timely Ruling on Cannabis Grow
From Iowaska Church to MMJ BioPharma Cultivation, Appellate Courts Patience with DEA's Inaction Wears Thin Amid Constitutional Challenges.Administrator Terrance "Terry"...
LED Operating Light Market Surges to USD 3.2 Billion by 2033, Propelled by 9.2% CAGR – Verified Market Reports®
LED operating light market is experiencing robust expansion driven by rising procedural volumes, growing adoption of minimally invasive surgery, and...
Electronic Data Capture Software Market is expected to generate a revenue of USD 4.06 Billion by 2031, Globally, at 14.5% CAGR: Verified Market Research®
The Electronic Data Capture Software Market is witnessing robust growth driven by the rising demand for decentralized clinical trials, real-time...
Pharmaceutical Quality Management Software Market worth $2.98 billion by 2030 with 13.3% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 17, 2025 /PRNewswire/ -- The global Pharmaceutical Quality Management Software Market, valued at US$1.41 billion in 2024,...
WCG CenterWatch Unveils Benchmarking Report Assessing AI Adoption in Clinical Research
CARY, N.C., Nov. 17, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
ZURICH and NESS ZIONA, Israel, Nov. 17, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or "the Company"), a clinical-stage...
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress
Presenting INTASYL siRNA Drug TechnologyKing of Prussia, Pennsylvania--(Newsfile Corp. - November 17, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is...
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Cash expected to fund operations into the second half of 2026Company focused on advancing next-generation anti-cancer therapies derived from well-established...
NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has...
Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA /...
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure...
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health...
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in...
Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy
OXFORD, England, Nov. 17, 2025 /PRNewswire/ -- Accession Therapeutics Limited, a biopharmaceutical company developing next generation cancer immunotherapies, today announced it...
Innerbloom Ketamine Therapy Expands Depression Treatment in San Luis Obispo With FDA-Approved SPRAVATO
Local Clinic Offers Newly Approved Monotherapy Option for Treatment-Resistant Depression - No Daily Antidepressant Required SAN LUIS OBISPO, CA /...
President Trumps Cannabis Decision Soon: From Hemp Shutdown to Pharmaceutical Clarity: MMJ Leads Federally Legal Cannabis Drug Development
"The federal hemp crackdown has created long overdue pharmaceutical clarity. MMJ is now the company advancing a fully compliant cannabinoid...
Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq
FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer...